News

BASF acquires global leader in omega-3 fatty acids for the pharmaceutical industry
May 9, 2012

BASF relocates production of Kolliphor TPGS to its Minden site
April 30, 2012

BASF introduces extended solubilization and dermatology excipients portfolios
April 12, 2012

News archive
Product Quick Finder

Innovation for Excipients

More

Service

Generic drug formul.

Publications

Order samples

Webinars

ExAct

Videos

Career

WorldAccount

Your online access to BASF

Read more
Page functions Tell a friend Contact Print
General information Disclaimer Data protection Credits © BASF SE 2011

Webinar

Hot Melt Extrusion for Poorly Soluble Drugs

October 6th, 2009 10:00 am - 11:00 am, Eastern Standard Time (New York)
  3:00 pm - 4:00 pm, GMT (London)

Hot Melt Extrusion (HME) is becoming an important technology within the Pharmaceutical Industry as a means for formulating poorly water-soluble active pharmaceutical ingredients (API’s). Additionally, HME provides greater drug bioavailability.

Read more

This Webinar will cover:

  • A review of Hot Melt Extrusion Technology.
  • Modification to the traditional extrusion system for pharmaceutical needs.
  • An economically-feasible continuous process and solvent-free manufacture.
  • The role of polymers and plasticizers.
  • The use of low temperatures to minimize API degradation.
  • Optimization of HME Formulation and Process.

Webinar speakers include:

Dr. Karl Kolter, Ph.D.

Head of Global R&D Project Management Excipients BASF SE, Germany, Pharma Ingredients and Services

Scott T. Martin

Senior Application Specialist
Thermo Fisher Scientific

 
back